Subscribe free

Intestine and Lower Gastrointestinal Tract ·

Nutritional Status in Metastatic Colorectal Cancer: No Benefit of Resection

Pretreatment nutritional and inflammatory markers do not identify patients with unresectable metastatic colorectal cancer who would benefit from primary tumor resection (PTR) over upfront chemotherapy.

  • In patients with a modified Glasgow prognostic score (MGPS) of 2 and hypoalbuminemia, PTR is linked to worse overall survival and progression-free survival compared to chemotherapy alone.
  • Specifically, in the MGPS 2 subgroup, PTR increased the risk of disease progression (hazard ratio 3.56; p = 0.049).

These findings reinforce the current practice of avoiding routine PTR in asymptomatic patients regardless of nutritional or inflammatory status.

Journal Article by Horino T, Komori K (…) Kanemitsu Y et 17 al. in Ann Surg Oncol

© 2026. Society of Surgical Oncology.

read the whole article in Ann Surg Oncol

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in Intestine and Lower Gastrointestinal Tract.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in Intestine and Lower Gastrointestinal Tract

The latest stitches

All papers in Intestine and Lower Gastrointestinal Tract →